comparemela.com

Latest Breaking News On - Tse well - Page 4 : comparemela.com

WELL Health Technologies (TSE:WELL) Sets New 12-Month High at $4 99

Shares of WELL Health Technologies Corp. (TSE:WELL – Get Rating) reached a new 52-week high on Friday . The stock traded as high as C$4.99 and last traded at C$4.97, with a volume of 589864 shares traded. The stock had previously closed at C$4.90. Wall Street Analyst Weigh In Several research analysts have weighed in […]

WELL Health Technologies Corp (TSE:WELL) Director Sells C$45,396 00 in Stock

WELL Health Technologies Corp. (TSE:WELL – Get Rating) Director Thomas Craig Liston sold 9,700 shares of the firm’s stock in a transaction on Friday, March 24th. The shares were sold at an average price of C$4.68, for a total value of C$45,396.00. WELL Health Technologies Price Performance TSE:WELL opened at C$4.72 on Friday. The business’s […]

WELL Health Technologies (TSE:WELL) Given New C$7 00 Price Target at CIBC

WELL Health Technologies (TSE:WELL – Get Rating) had its price objective boosted by CIBC from C$6.50 to C$7.00 in a research note published on Wednesday morning, BayStreet.CA reports. They currently have an outperform rating on the stock. WELL Health Technologies Stock Performance Shares of WELL opened at C$4.66 on Wednesday. The firm has a market […]

WELL Health Technologies Corp (TSE:WELL) Given Average Recommendation of Buy by Analysts

Shares of WELL Health Technologies Corp. (TSE:WELL – Get Rating) have earned a consensus recommendation of “Buy” from the eight brokerages that are currently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have updated their coverage on the stock […]

WELL Health Technologies Corp (TSE:WELL) Given Consensus Recommendation of Buy by Brokerages

WELL Health Technologies Corp. (TSE:WELL – Get Rating) has been given a consensus recommendation of “Buy” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have covered the stock in the last […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.